CROI 2010: Once Daily Next Generation Integrase Inhibitor
Discussion around GlaxoSmithKline's new once daily Integrase Inhibitor, S/GSK1349572.
S/GSK1349572 is a novel integrase inhibitor with potent in vitro anti-HIV activity, an in vitro resistance profile different from those of other integrase inhibitors, and favorable preclinical safety and pharmacokinetics (PK).
Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!